PHILADELPHIA – Troutman Pepper Locke represented Vishay Intertechnology, Inc. (Vishay) (Nasdaq: VSH), one of the world’s largest portfolios of discrete semiconductors and passive electronic components that are essential to innovative designs in the automotive, industrial, computing, consumer, telecommunications, military, aerospace, and health care markets, in its underwritten public offering of 17,250,000 shares of its common stock at a price of $50 per share.
The offering raised approximately $862.5 million in gross proceeds, before deducting underwriting discounts and commissions and other expenses of the offering. The company intends to use the net proceeds from the offering to accelerate its growth initiatives and for general corporate purposes, including reducing current borrowings under its senior secured credit facility.
The Troutman Pepper Locke team that advised Vishay includes Barry Abelson, Brian Katz, David Wolpa, Betty Segaar, Gabby Gaudet, Grace Fortmann, Mark Goldsmith, and Caitlin Oh.
Consistently recognized as a top-tier practice, Troutman Pepper Locke’s corporate attorneys leverage broad experience and deep industry knowledge to help clients navigate global markets and achieve their capital-raising objectives. The firm’s capital markets team is regularly recognized in industry league table rankings released by LSEG and Bloomberg, maintaining top rankings internationally and in the Americas. They focus on minimizing regulatory and economic risks while positioning clients for potential opportunities. The firm represents domestic and foreign issuers, underwriters, selling and controlling shareholders, and other market participants in a wide range of capital markets transactions.
Troutman Pepper Locke
Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.